Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Migraine

Free Subscription Articles published in Lancet Retrieve available abstracts of 8 articles: HTML format

Single Articles

November 2023
1. DODICK DW, Goadsby PJ, Schwedt TJ, Lipton RB, et al
   Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA.
   Lancet. 2023 Nov 15:S0140-6736(23)01683-5. doi: 10.1016/S0140-6736(23)01683.
   PubMed     Abstract available
   
   
   July 2023
2. POZO-ROSICH P, Ailani J, Ashina M, Goadsby PJ, et al
   Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
   Lancet. 2023 Jul 26:S0140-6736(23)01049-8. doi: 10.1016/S0140-6736(23)01049.
   PubMed     Abstract available
   
   
   
3. HAANES KA, Edvinsson L
   Atogepant, the first oral preventive treatment for chronic migraine.
   Lancet. 2023 Jul 26:S0140-6736(23)01462-9. doi: 10.1016/S0140-6736(23)01462.
   PubMed    
   
   
   March 2021
4. ASHINA M, Katsarava Z, Do TP, Buse DC, et al
   Migraine: epidemiology and systems of care.
   Lancet. 2021 Mar 25. pii: S0140-6736(20)32160.
   PubMed     Abstract available
   
   
   
5. ASHINA M, Buse DC, Ashina H, Pozo-Rosich P, et al
   Migraine: integrated approaches to clinical management and emerging treatments.
   Lancet. 2021 Mar 25. pii: S0140-6736(20)32342.
   PubMed     Abstract available
   
   
   
6. ASHINA M, Terwindt GM, Al-Karagholi MA, de Boer I, et al
   Migraine: disease characterisation, biomarkers, and precision medicine.
   Lancet. 2021 Mar 25. pii: S0140-6736(20)32162.
   PubMed     Abstract available
   
   
   December 2020
7. CROOP R, Lipton RB, Kudrow D, Stock DA, et al
   Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial.
   Lancet. 2020 Dec 15. pii: S0140-6736(20)32544.
   PubMed     Abstract available
   
   
   
8. EDVINSSON L
   Oral rimegepant for migraine prevention.
   Lancet. 2020 Dec 15. pii: S0140-6736(20)32624.
   PubMed    
   
   

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.